$SSKN
STRATA Skin Sciences, Inc.

2022 Q1 Form 10-Q Financial Statement

#000114036122018639 Filed on May 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $7.041M $5.827M
YoY Change 20.83% -13.42%
Cost Of Revenue $2.913M $2.114M
YoY Change 37.8% -9.31%
Gross Profit $4.128M $3.713M
YoY Change 11.18% -15.59%
Gross Profit Margin 58.63% 63.72%
Selling, General & Admin $6.268M $5.721M
YoY Change 9.56% 13.18%
% of Gross Profit 151.84% 154.08%
Research & Development $163.0K $384.0K
YoY Change -57.55% 31.51%
% of Gross Profit 3.95% 10.34%
Depreciation & Amortization $625.0K $481.0K
YoY Change 29.94% -17.92%
% of Gross Profit 15.14% 12.95%
Operating Expenses $6.431M $6.105M
YoY Change 5.34% 14.18%
Operating Profit -$2.303M -$2.392M
YoY Change -3.72% 152.32%
Interest Expense $199.0K $30.00K
YoY Change 563.33%
% of Operating Profit
Other Income/Expense, Net -$199.0K -$22.00K
YoY Change 804.55% -2300.0%
Pretax Income -$2.502M -$2.414M
YoY Change 3.65% 154.91%
Income Tax $0.00 $4.000K
% Of Pretax Income
Net Earnings -$2.502M -$2.418M
YoY Change 3.47% 133.62%
Net Earnings / Revenue -35.53% -41.5%
Basic Earnings Per Share -$0.07 -$0.07
Diluted Earnings Per Share -$0.07 -$0.07
COMMON SHARES
Basic Shares Outstanding 34.68M 33.80M
Diluted Shares Outstanding 34.68M 33.80M

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.92M $10.04M
YoY Change 8.79% 23.19%
Cash & Equivalents $10.92M $10.04M
Short-Term Investments
Other Short-Term Assets $393.0K $7.890M
YoY Change -95.02% -1.0%
Inventory $4.758M $3.312M
Prepaid Expenses
Receivables $2.972M $2.853M
Other Receivables $0.00 $0.00
Total Short-Term Assets $19.05M $24.10M
YoY Change -20.98% 5.73%
LONG-TERM ASSETS
Property, Plant & Equipment $6.921M $5.788M
YoY Change 19.57% 7.6%
Goodwill $8.803M
YoY Change 0.0%
Intangibles $5.993M
YoY Change -20.13%
Long-Term Investments
YoY Change
Other Assets $200.0K $265.0K
YoY Change -24.53% -19.7%
Total Long-Term Assets $36.04M $21.75M
YoY Change 65.7% -6.45%
TOTAL ASSETS
Total Short-Term Assets $19.05M $24.10M
Total Long-Term Assets $36.04M $21.75M
Total Assets $55.09M $45.85M
YoY Change 20.14% -0.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.970M $3.151M
YoY Change 25.99% 49.9%
Accrued Expenses $6.539M $5.286M
YoY Change 23.7% 2.64%
Deferred Revenue $3.121M $2.208M
YoY Change 41.35% 14.17%
Short-Term Debt $0.00 $7.280M
YoY Change -100.0% 0.0%
Long-Term Debt Due $1.811M
YoY Change
Total Short-Term Liabilities $14.42M $20.11M
YoY Change -28.29% 19.65%
LONG-TERM LIABILITIES
Long-Term Debt $7.356M $717.0K
YoY Change 925.94%
Other Long-Term Liabilities $9.266M $24.00K
YoY Change 38508.33% -79.83%
Total Long-Term Liabilities $16.62M $741.0K
YoY Change 2143.18% 522.69%
TOTAL LIABILITIES
Total Short-Term Liabilities $14.42M $20.11M
Total Long-Term Liabilities $16.62M $741.0K
Total Liabilities $31.31M $21.72M
YoY Change 44.15% 20.66%
SHAREHOLDERS EQUITY
Retained Earnings -$221.4M
YoY Change 2.69%
Common Stock $34.00K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.78M $24.14M
YoY Change
Total Liabilities & Shareholders Equity $55.09M $45.85M
YoY Change 20.14% -0.42%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income -$2.502M -$2.418M
YoY Change 3.47% 133.62%
Depreciation, Depletion And Amortization $625.0K $481.0K
YoY Change 29.94% -17.92%
Cash From Operating Activities -$353.0K $153.0K
YoY Change -330.72% -74.41%
INVESTING ACTIVITIES
Capital Expenditures -$679.0K $86.00K
YoY Change -889.53%
Acquisitions $631.0K
YoY Change
Other Investing Activities -$631.0K
YoY Change
Cash From Investing Activities -$1.310M -$740.0K
YoY Change 77.03% 24.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -353.0K 153.0K
Cash From Investing Activities -1.310M -740.0K
Cash From Financing Activities
Net Change In Cash -1.663M -587.0K
YoY Change 183.3% -29450.0%
FREE CASH FLOW
Cash From Operating Activities -$353.0K $153.0K
Capital Expenditures -$679.0K $86.00K
Free Cash Flow $326.0K $67.00K
YoY Change 386.57% -88.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001051514
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3121000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3285000
CY2022Q1 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
500000
CY2021Q4 us-gaap Asset Acquisition Contingent Consideration Liability Current
AssetAcquisitionContingentConsiderationLiabilityCurrent
0
CY2022Q1 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
320000
CY2021Q4 us-gaap Other Liabilities And Deferred Revenue Noncurrent
OtherLiabilitiesAndDeferredRevenueNoncurrent
400000
CY2022Q1 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
8622000
CY2021Q4 us-gaap Asset Acquisition Contingent Consideration Liability Noncurrent
AssetAcquisitionContingentConsiderationLiabilityNoncurrent
0
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2789000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
6431000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6105000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2303000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2392000
CY2022Q1 us-gaap Interest Expense
InterestExpense
199000
CY2021Q1 us-gaap Interest Expense
InterestExpense
30000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2502000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2418000
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-199000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-22000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2502000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2414000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7041000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5827000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2913000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
2114000
CY2022Q1 us-gaap Gross Profit
GrossProfit
4128000
CY2021Q1 us-gaap Gross Profit
GrossProfit
3713000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
384000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3616000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2932000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2652000
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34679246
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34679246
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33802129
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33802129
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25414000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
368000
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
500000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-2502000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
23780000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
25892000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
662000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2418000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
24136000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
696000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
352000
CY2022Q1 us-gaap Depreciation
Depreciation
625000
CY2021Q1 us-gaap Depreciation
Depreciation
481000
CY2022Q1 sskn Amortization Of Debt Issuance Costs And Debt Discount Premium
AmortizationOfDebtIssuanceCostsAndDebtDiscountPremium
37000
CY2021Q1 sskn Amortization Of Debt Issuance Costs And Debt Discount Premium
AmortizationOfDebtIssuanceCostsAndDebtDiscountPremium
0
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-257000
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-54000
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
71000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
0
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
10182000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
0
CY2022Q1 sskn Noncash Or Part Noncash Acquisition Contingent Consideration Issued In Connection With Asset Acquisition
NoncashOrPartNoncashAcquisitionContingentConsiderationIssuedInConnectionWithAssetAcquisition
9122000
CY2021Q1 sskn Noncash Or Part Noncash Acquisition Contingent Consideration Issued In Connection With Asset Acquisition
NoncashOrPartNoncashAcquisitionContingentConsiderationIssuedInConnectionWithAssetAcquisition
0
CY2022Q1 us-gaap Stock Issued1
StockIssued1
500000
CY2021Q1 us-gaap Stock Issued1
StockIssued1
0
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Reclassifications</div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation. These reclassifications did not have a material impact on the Company’s stockholders’ equity, results of operations, or cash flows.</div>
CY2022Q1 us-gaap Use Of Estimates
UseOfEstimates
<div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As of March 31, 2022, the more significant estimates include revenue recognition with respect to deferred revenues and the contract term and valuation allowances of accounts receivable, inputs used when evaluating goodwill for impairment, inputs used in the valuation of acquired intangible assets, state sales and tax accruals, the estimated useful lives of intangible assets, and the valuation allowance related to deferred tax assets.</div>
CY2021Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
63000
CY2022Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
33000
CY2021Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
22000
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
79000
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
113000
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
34000
CY2021Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4000
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
14000
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
32000
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
99000
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
85000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
66000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4898021
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6925478
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10000
CY2022Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q1 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
10000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
11000
CY2022Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
5000
CY2021Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
34000
CY2022Q1 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3881000
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3201000
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
877000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
288000
CY2022Q1 us-gaap Inventory Net
InventoryNet
4758000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3489000
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27261000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26654000
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20340000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19771000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6921000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6883000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
625000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
481000
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31596000
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12028000
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19568000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21414000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11331000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10083000
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
696000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
352000
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2175000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2871000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2871000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2166000
CY2022Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1461000
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
66000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
59000
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1992000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2052000
CY2022Q1 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3739000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3697000
CY2022Q1 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
742000
CY2021Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
569000
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6539000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6377000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
1000000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
4000000
CY2022Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
3000000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
368000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
662000
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.896
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.024
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
35000
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y3M18D
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2303000
CY2022Q1 us-gaap Interest Expense
InterestExpense
199000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2502000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2414000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7041000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
2913000
CY2022Q1 us-gaap Gross Profit
GrossProfit
4128000
CY2022Q1 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.586
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
163000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3616000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2652000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
6431000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5827000
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
2114000
CY2021Q1 us-gaap Gross Profit
GrossProfit
3713000
CY2021Q1 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.637
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
384000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2932000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2789000
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
6105000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2392000
CY2021Q1 us-gaap Interest Expense
InterestExpense
30000
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
8000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7041000
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5827000
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
113000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
116000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
113000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
116000
CY2022Q1 sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0976
CY2022Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M18D
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
258000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
242000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
186000
CY2022Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
686000
CY2022Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
73000
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
613000
CY2022Q1 sskn Development Agreement Term
DevelopmentAgreementTerm
P3Y

Files In Submission

Name View Source Status
0001140361-22-018639-index-headers.html Edgar Link pending
0001140361-22-018639-index.html Edgar Link pending
0001140361-22-018639.txt Edgar Link pending
0001140361-22-018639-xbrl.zip Edgar Link pending
brhc10037199_10q.htm Edgar Link pending
brhc10037199_10q_htm.xml Edgar Link completed
brhc10037199_ex10-2.htm Edgar Link pending
brhc10037199_ex10-3.htm Edgar Link pending
brhc10037199_ex10-4.htm Edgar Link pending
brhc10037199_ex31-1.htm Edgar Link pending
brhc10037199_ex31-2.htm Edgar Link pending
brhc10037199_ex32-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image00004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20220331.xsd Edgar Link pending
sskn-20220331_cal.xml Edgar Link unprocessable
sskn-20220331_def.xml Edgar Link unprocessable
sskn-20220331_lab.xml Edgar Link unprocessable
sskn-20220331_pre.xml Edgar Link unprocessable